ORIC Pharmaceuticals, Inc. (ORIC) Tops Q3 EPS by 2c

ORIC Pharmaceuticals, Inc. (NASDAQ: ORIC) reported Q3 EPS of ($0.44), $0.02 better than the analyst estimate of ($0.46).

For earnings history and earnings-related data on ORIC Pharmaceuticals, Inc. (ORIC) click here.

You May Also Be Interested In

• Elon Musk’s trillion-dollar meltdown: How SpaceX and Tesla erased $700 billion
• Microchip Technology to acquire edge AI chip firm Hailo
• NextEra Energy (NEE) Tops Q2 EPS by 6c